From: Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol
Inclusion criteria | |
1. | Pregnant females 18.0 years and older 12 to 20 weeks of gestation at study entry |
2. | Agree to consume study capsules and a typical prenatal supplement of 200 mg DHA |
3. | Available by telephone |
4. | English or Spanish speaking |
Exclusion criteria | |
1. | Less than 18 years of age |
2. | Expecting multiple infants |
3. | Gestational age at baseline <12 weeks or >20 weeks |
4. | Unable or unwilling to agree to consume capsules until delivery |
5. | Unwilling to discontinue use of another prenatal supplement with DHA |
6. | Women with allergy to any component of DHA product (including algae), soybean oil or corn oil |